Founded in 2006, Santé Ventures is a specialized healthcare and life sciences investment firm managing nearly $1 billion in capital. The firm focuses on early-stage companies developing innovative medical technologies, biotechnologies, and digitally enabled healthcare services. Santé Ventures typically leads or co-leads Seed or Series A fundraising rounds, aiming to build a portfolio of 15-25 investments in companies with the potential to deliver better health outcomes at lower costs.

Notable successes include Farapulse (acquired by Boston Scientific), Claret Medical (acquired by Boston Scientific), TVA Medical (acquired by Becton Dickinson), Millipede Medical (acquired by Boston Scientific), Molecular Templates (MTEM), AbVitro (acquired by Celgene), and Explorys (acquired by IBM Corp).